Identification of structure–activity relationships for...

Identification of structure–activity relationships for adverse effects of pharmaceuticals in humans. Part A: Use of FDA post-market reports to create a database of hepatobiliary and urinary tract toxicities

Carling J. Ursem, Naomi L. Kruhlak, Joseph F. Contrera, Philip M. MacLaughlin, R. Daniel Benz, Edwin J. Matthews
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
54
Year:
2009
Language:
english
Pages:
22
DOI:
10.1016/j.yrtph.2008.12.009
File:
PDF, 315 KB
english, 2009
Conversion to is in progress
Conversion to is failed